AnaptysBio, Inc. (ANAB) Social Stream
ANAPTYSBIO INC (ANAB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ANAPTYSBIO INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 6 | $50 | $19 | $35 | $18.48 | 89.39% |
| 2022-03-07 | 6 | $50 | $25 | $36 | $18.48 | 94.81% |
| 2022-03-15 | 6 | $50 | $25 | $36.166 | $18.48 | 95.7% |
| 2022-03-18 | 7 | $50 | $24 | $36 | $18.48 | 94.81% |
| 2022-05-05 | 6 | $50 | $24 | $34 | $18.48 | 83.98% |
| 2022-05-12 | 6 | $50 | $23 | $33.8 | $18.48 | 82.9% |
| 2022-08-09 | 5 | $50 | $23 | $32.25 | $18.48 | 74.51% |
| 2022-08-11 | 5 | $50 | $23 | $32.5 | $18.48 | 75.87% |
| 2022-09-01 | 6 | $50 | $23 | $31.2 | $18.48 | 68.83% |
| 2022-09-13 | 7 | $30 | $21 | $25.2 | $18.48 | 36.36% |
| 2022-09-19 | 7 | $35 | $21 | $26.833 | $18.48 | 45.2% |
| 2022-11-01 | 7 | $44 | $21 | $29.285 | $18.48 | 58.47% |
| 2022-11-09 | 7 | $44 | $23 | $32 | $18.48 | 73.16% |
| 2022-11-21 | 7 | $44 | $23 | $33.142 | $18.48 | 79.34% |
| 2023-01-06 | 7 | $44 | $23 | $31.833 | $18.48 | 72.26% |
| 2023-03-02 | 6 | $44 | $28 | $32.2 | $18.48 | 74.24% |
| 2023-05-11 | 6 | $44 | $28 | $32 | $18.48 | 73.16% |
| 2023-05-12 | 7 | $45 | $22 | $31 | $18.48 | 67.75% |
| 2023-05-22 | 7 | $45 | $22 | $30.8 | $18.48 | 66.67% |
The Trend in the Analyst Price Target
Over the past 12 months, ANAB's average price target has gone down $4.2.
ANAB reports an average of 31.66% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-01 | 7 | 44 | 21 | 29.285 | 29.60 | -1.06% |
| 2022-11-21 | 7 | 44 | 23 | 33.142 | 27.04 | 22.57% |
| 2023-04-12 | 6 | 44 | 28 | 32.000 | 21.13 | 51.44% |
| 2023-05-12 | 6 | 45 | 22 | 31.000 | 19.45 | 59.38% |
| 2023-05-22 | 7 | 45 | 22 | 30.800 | 19.98 | 54.15% |
ANAB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.43 | 2 | 0 | 5 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
ANAB's average broker recommendation rating improved by 0 over the prior 120 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ANAB as an investment opportunity.
- ANAB has a lower variance in analysts' estimates than -1789.7% of all US stocks.
- In the context of all US stocks, ANAPTYSBIO INC's number of analysts covering the stock is higher than 819.22% of them.
- To contextualize these metrics, consider that out of all US stocks, ANAPTYSBIO INC's upside potential (average analyst target price relative to current price) is higher than 1728.91% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ANAPTYSBIO INC's average analyst price target is higher than 1463.01% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ANAPTYSBIO INC are RETA, AXSM, and MCRB.
View All Top Stocks by Price Target
Is ANAB a Buy, Hold or Sell? See the POWR Ratings now!